Red light therapy for myopia: Merits, risks and questions
Ophthalmic and Physiological Optics · 2024-07 · 44 (5) · 801-807
DOI: 10.1111/opo.13306 ↗Kurz gefasst
Editorial in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 02.04.2024. Verfasst von Frank Schaeffel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland. Hauptthemen laut MEDLINE: Myopia, Phototherapy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
- Section of Neurobiology of the Eye, Ophthalmic Research Institute, University of Tuebingen, Tuebingen, Germany.
- Herbert Wertheim School of Optometry and Vision Science, University California Berkeley, Berkeley, California, USA.
- School of Optometry and Vision Science, Queensland University of Technology, Brisbane, Queensland, Australia.
ORCID-Profile: Frank Schaeffel, Christine F Wildsoet
Zitieren
APA
Schaeffel, F., & Wildsoet, C. F. (2024). Red light therapy for myopia: Merits, risks and questions. Ophthalmic and Physiological Optics, 44(5), 801-807. https://doi.org/10.1111/opo.13306
Vancouver
Schaeffel F, Wildsoet CF. Red light therapy for myopia: Merits, risks and questions. Ophthalmic and Physiological Optics. 2024;44(5):801-807. doi:10.1111/opo.13306
BibTeX
@article{Schaeffel2024,
author = {Schaeffel, Frank and Wildsoet, Christine F},
title = {Red light therapy for myopia: Merits, risks and questions},
journal = {Ophthalmic and Physiological Optics},
year = {2024},
volume = {44},
number = {5},
pages = {801--807},
doi = {10.1111/opo.13306}
}
EUVIMED